MiniMed Group, Inc. IPO Research Information

MiniMed Group, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on MiniMed Group, Inc. , and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
MiniMed Group, Inc.	MMED - NASDAQ	$25.00-$28.00	$20.00	$19.05	28 million	3/6/2026
Underwriter(s): Goldman Sachs, BofA Securities, Citigroup, Morgan Stanley, Barclays, Deutsche Bank, Mizuho, Wells Fargo
Co-Manager(s): Evercore ISI, Piper Sandler, BTIG, William Blair
Industry: Health Care
Filing(s): Filed 2025-12-19 Terms Added 2026-02-24

MiniMed Group, Inc. Quote & Chart - Click for current quote - MMED

About MiniMed Group, Inc. (adapted from MiniMed Group, Inc. prospectus):
They are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MMED" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.